BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 9122728)

  • 1. Detection of occult melanoma cells in sentinel lymph nodes and blood.
    Reintgen DS; Conrad AJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 4):S11-5. PubMed ID: 9122728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.
    Davids V; Kidson SH; Hanekom GS
    Melanoma Res; 2003 Jun; 13(3):313-24. PubMed ID: 12777989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
    Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
    Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy and melanoma biology.
    Essner R
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2320s-2325s. PubMed ID: 16609052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
    Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
    Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective.
    Queirolo P; Taveggia P; Gipponi M; Sertoli MR
    J Surg Oncol; 2004 Mar; 85(3):162-5. PubMed ID: 14991888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in head and neck squamous cell carcinoma.
    Pitman KT; Johnson JT; Brown ML; Myers EN
    Laryngoscope; 2002 Dec; 112(12):2101-13. PubMed ID: 12461328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of nodal metastases in melanoma using sox-10.
    Jennings C; Kim J
    Am J Dermatopathol; 2011 Jul; 33(5):474-82. PubMed ID: 21552103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.
    Kammula US; Ghossein R; Bhattacharya S; Coit DG
    J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
    Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
    Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of circulating neoplastic cells by reverse transcriptase and polymerase chain reaction in melanoma].
    Tessier MH; Denis MG; Lustenberger P; Dreno B
    Ann Dermatol Venereol; 1997; 124(9):607-11. PubMed ID: 9739921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathobiology of the sentinel node.
    Cochran AJ; Ohsie SJ; Binder SW
    Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis in evaluating the sentinel node in malignant melanoma.
    Sung J; Li W; Shivers S; Reintgen D
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):29S-30S. PubMed ID: 11599893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.